Dichlororibofuranosylbenzimidazole vs tetrabromobenzotriazole
Mechanistic comparison of Dichlororibofuranosylbenzimidazole and tetrabromobenzotriazole based on molecular target overlap from BindingDB and ChEMBL binding affinity data.
2
Shared Targets
18%
Jaccard Similarity
17%
IDF-Weighted Similarity
Jaccard measures raw target overlap. IDF-weighted downweights promiscuous hub targets (e.g. CYP enzymes) that bind many compounds non-specifically.
Evidence Comparison
Target Overlap
Dichlororibofuranosylbenzimidazole and tetrabromobenzotriazole share 2 molecular targets based on binding affinity data from BindingDB (Kd/IC50 ≤ 10 µM) and ChEMBL. A Jaccard index of 0.182 means 18% of the combined target set is bound by both compounds. The IDF-weighted score of 0.166 accounts for non-specific binding to metabolic enzymes.
Note: High target overlap does not imply identical mechanism or therapeutic equivalence. Binding affinity, tissue distribution, bioavailability, and downstream signaling differ significantly between compounds even when they bind the same protein.
Frequently Asked Questions
Related Comparisons
Similar to Dichlororibofuranosylbenzimidazole
Dichlororibofuranosylbenzimidazole vs Aminocaproic2 targetsDichlororibofuranosylbenzimidazole vs Dinitrochlorobenzene6 targetsDichlororibofuranosylbenzimidazole vs Desoxycorticosterone4 targetsDichlororibofuranosylbenzimidazole vs quinalizarin2 targetsDichlororibofuranosylbenzimidazole vs Melphalan5 targets